✦ LIBER ✦

Neurosurgical convection-enhanced delivery of treatments for Parkinson’s disease

✍ Scribed by Miu Fei Lam; Meghan G. Thomas; Christopher R.P. Lind

Book ID: 116676089
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 448 KB
Volume: 18
Category: Article
ISSN: 0967-5868
DOI: 10.1016/j.jocn.2011.01.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advances in the delivery of treatments f

Advances in the delivery of treatments for Parkinson’s disease

✍ Johnston, Tom H; Fox, Susan H; Brotchie, Jonathan M 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 210 KB

Rotigotine transdermal delivery for the

Rotigotine transdermal delivery for the treatment of Parkinson's disease

✍ Rascol, Olivier; Perez-Lloret, Santiago 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 703 KB

Sustained delivery of GDNF: towards a tr

Sustained delivery of GDNF: towards a treatment for Parkinson’s disease

✍ Anne D Zurn; Hans R Widmer; Patrick Aebischer 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 910 KB

Image-Guided Convection-Enhanced Deliver

Image-Guided Convection-Enhanced Delivery Platform in the Treatment of Neurological Diseases

✍ Massimo S. Fiandaca; John R. Forsayeth; Peter J. Dickinson; Krystof S. Bankiewic 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 200 KB

Convection-enhanced delivery (CED) of substances within the human brain is becoming a more frequent experimental treatment option in the management of brain tumors, and more recently in phase 1 trials for gene therapy in Parkinson's disease (PD). Benefits of this intracranial drug-transfer technolog

Levodopa delivery systems for the treatm

Levodopa delivery systems for the treatment of Parkinson's disease: An overview

✍ J. Goole; K. Amighi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 935 KB

Viral delivery of GDNF for Parkinson's d

Viral delivery of GDNF for Parkinson's disease

✍ Rebecca Love 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 54 KB